A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 01, 2023
- Source ID
- 10.1016/j.vaccine.2023.04.064
Entities
People
- Allison August
- Christine A Shaw
- Conor Knightly
- Honghong Zhou
- Lori Panther
- Peta-gay Jackson Booth
- Scott C. Weaver
- Stephan Bart
- Trevor Brasel
Organizations
- Defense Advanced Research Projects Agency
- Moderna